Investigating the role of cathepsins in breast cancer progression: a Mendelian randomization study
BackgroundBreast cancer, a major threat to women’s health worldwide, has mechanisms of onset that remain unclear. Within the human lysosomal system, a class of enzymes known as cathepsins exhibit elevated expression levels in various malignant tumors, suggesting that they may play key roles in cance...
Saved in:
Main Authors: | Shengyi Zhou, Yizhou Sun, Wenzhang Zha, Guangjun Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1408723/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetic association of lipid-lowering drug target genes with pancreatic cancer: a Mendelian randomization study
by: Bohan Su, et al.
Published: (2025-01-01) -
Associations between lipid-lowering drugs and urate and gout outcomes: a Mendelian randomization study
by: Min Liu, et al.
Published: (2025-01-01) -
Insights Into Causal Effects of Genetically Proxied Lipids and Lipid‐Modifying Drug Targets on Cardiometabolic Diseases
by: Liwan Fu, et al.
Published: (2025-02-01) -
Single-cell transcriptome-wide Mendelian randomization and colocalization reveals immune-mediated regulatory mechanisms and drug targets for COVID-19Research in context
by: Hui Ying, et al.
Published: (2025-03-01) -
Genetic Insights Into the Role of Cathepsins in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis: Evidence From Mendelian Randomization Study
by: Yanhong Jiang, et al.
Published: (2025-01-01)